News & Updates
Influenza Research Consortium Announces £1.2 million (C$2.2 million) in Funding for the Development of a Novel Broad-Spectrum Influenza Vaccine
July 7, 2025
Read More
Pegasus Biotech Announces Filing of Provisional Patent Application for BPE Plasmid Technology
April 1, 2024
Read More
Pegasus Biotech Receives Designated Status Under the Atlantic Immigration Program
April 20, 2022
Read More